
    
      This stage I study is designed to evaluate the appropriate dose of S-1 plus radiotherapy for
      patients with R0 resection of rectal cancer for stage II-III patients(AJCC 7th). To evaluate
      safety, data on adverse events will be collected from the time of enrollment until withdrawn
      of complete whole study.
    
  